Patrick Clegg, DO
Physical Medicine & Rehabilitation · Greenville, NCNPI 1164985768
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,728 of the $2,105 with a category attached, or 82.1%. AbbVie accounts for 94.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,918 and has fallen 96.1% since, to $75 in 2025.
Across 12 payments — averaging $175.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Merz Pharmaceuticals, LLC$85
- AstraZeneca$15
- Penumbra, Inc.$13
What the payments were for
- Travel & lodging$1,72882%
- Food & beverage$29314%
- Education$854%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $1,992 |
| Merz Pharmaceuticals, LLC | 1 | $85 |
| AstraZeneca | 1 | $15 |
| Penumbra, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$1,837
How this compares
$2,105 in reported general payments places this provider in the 80th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
See all physical medicine & rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $31,093 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $1,414 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $743 |
| Gabapentin | 66 | $700 |
| Pantoprazole Sodium | 93 | $696 |
| Duloxetine Hcl | 19 | $435 |
| Midodrine Hcl | 18 | $429 |
| Atorvastatin Calcium | 88 | $390 |
| Omeprazole | 44 | $366 |
| Metformin Hcl | 27 | $315 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $273 |
| Levetiracetam | 22 | $263 |
| Nitroglycerin | 25 | $257 |
| Amlodipine Besylate | 57 | $249 |
| Tamsulosin Hcl | 29 | $247 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Greenville
- Elizabeth BagsbyGreenville$33K
- Billy SmithGreenville$10K
- Ratnakar VeeramachaneniGreenville$8K
- Jason GuoGreenville$3K
- William RieckGreenville$3K
- Andrew SumichCharlotte$181K
- Patrick O BrienRaleigh$86K
- Krishna BhatSanford$30K
- Jasbir DhaliwalSanford$23K
- Jimmy MaliDurham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.